In March 2025, the company announced new plans to get a direct-to-consumer supplying of its Wegovy weight loss drug. The company proven a brand new pharmacy, referred to as NovoCare, which would charge clients $499 per 30 days for use of the drug, under fifty percent the expense of the drug through other pharmaceutical distribution networks.[53]Not